(2008). [Survival and immune response of rural HIV/AIDS patients after free antiretroviral therapy]. Zhonghua Liu Xing Bing Xue Za Zhi
(1999). Aiuti F: Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS
(2005). Campo E: Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence. Mod Pathol
(2007). Cao GH: Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes. J Acquir Immune Defic Syndr
(2005). Cao H: T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
(2000). Connor RI: Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
(2003). Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS
(1994). DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
(2002). Detels R: Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr
(1999). DF: Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.
(1998). Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAARTtreated HIV-1-infected children. Highly active antiretroviral therapy. Lancet
(1995). Herzenberg LA: Altered representation of naive and memory CD8 T cell subsets in HIV-infected children.
(1995). Herzenberg LA: CD8 naive T cell counts decrease progressively in HIV-infected adults.
(2003). Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J Acquir Immune Defic Syndr
(2001). L: Preferential localization of effector memory cells in nonlymphoid tissue. Science
(1999). Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature
(2010). Liu C: Evaluation of a 6-year highly active antiretroviral therapy in Chinese HIV-1-infected patients. Intervirology
(1999). Measurement of T-cell kinetics: recent methodologic advances. Immunol Today
(2007). Meyerhans A: Maintenance of HIV-specific central and effector memory CD4 and CD8 T cells requires antigen persistence. AIDS Res Hum Retroviruses
(1994). Oldstone MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
(1997). Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science
(1998). Reichman RC: Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells. Antiviral Res
(2000). S: Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virusinfected children. J Infect Dis
(1998). Schellekens PT: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med
(1998). Sinet M: Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS
(2000). The dynamics of T-lymphocyte turnover in AIDS. AIDS